The Galapagos pipeline spans both oncology and immunology, but in recent years, the company has invested heavily in cancer cell therapy. The firm is now fully embracing the modality, announcing on ...

Akadeum Life Sciences, the leader in buoyant microbubble cell separation, today announced that its Chief Executive Officer Brandon McNaughton, PhD, will present at Biotech Showcase (TM) 2026 in San ...

Cell separation technologies have significant implications in clinical settings as well. They are employed in the isolation and purification of rare cells, such as circulating tumor cells or stem ...

Separation devices like cell strainers are indispensable tools in laboratories, enabling the filtration, purification, and isolation of cells from heterogeneous mixtures. Pluriselect has taken these ...

Cayman Chemical, a global provider of life science research tools, and Akadeum Life Sciences, a leader in buoyancy-based cell separation technology, announced today a distribution partnership to ...

When Galapagos and Gilead Sciences entered a global drug R&D collaboration six years ago, the deal focused on Galapagos’s capabilities as a developer of small molecule drugs. Fast forward to today, ...

Using a non-traditional, micro-organism separation method, researchers at Rochester Institute of Technology discovered a faster technique that can be used to distinguish cells that are resistant to ...